Looking at the universe of stocks we cover at Dividend Channel, on 1/17/17, Solar Senior Capital Limited (SUNS - Get Report) will trade ex-dividend, for its monthly dividend of $0.1175, payable on 2/1/17. As a percentage of SUNS's recent stock price of $16.82, this dividend works out to approximately 0.70%, so look for shares of Solar Senior Capital Limited to trade 0.70% lower — all else being equal — when SUNS shares open for trading on 1/17/17.Below is a dividend history chart for SUNS, showing historical dividends prior to the most recent $0.1175 declared by Solar Senior Capital Limited: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from SUNS is likely to continue, and whether the current estimated yield of 8.39% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of SUNS shares, versus its 200 day moving average: Looking at the chart above, SUNS's low point in its 52 week range is $12.80 per share, with $17.09 as the 52 week high point — that compares with a last trade of $16.83. In Friday trading, Solar Senior Capital Limited shares are currently down about 0.2% on the day.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Ear to the Ground on UTX-Raytheon: What Needs to Happen for the Deal to Close
Shareholders are skittish about this deal, one analyst said. See why they shouldn't be.
AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential
AbbVie's deal for Allergan will give it a new revenue stream in Botox, helping offset potential lower revenue from arthritis drug Humira, which is losing patent protection.
Care.com Shares Slump After Chief Financial Officer Resigns
Care.com's finance chief resigns a few months after a Wall Street Journal report that many day-care centers listed on the company's site were unlicensed.
Dow Ends Down on Mixed Trade Messages From Mnuchin, Trump
Stocks end mixed after Treasury Secretary Steven Mnuchin says the U.S. and China were close to reaching a trade agreement, while President Trump hints that he wants to make a trade deal with Beijing but is happy where things are now.